Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making

Abstract

This study suggests that oncologists rarely express that a treatment decision needs to be made in consultations concerning preference-sensitive treatment decisions. Therefore, patients might not realize that foregoing (neo-)adjuvant treatment is a viable choice. Oncologists miss a crucial opportunity to facilitate SDM.